Medication use during pregnancy and lactation: An urgent call for public health action

被引:58
|
作者
Lagoy, CT [1 ]
Joshi, N [1 ]
Cragan, JD [1 ]
Rasmussen, SA [1 ]
机构
[1] Natl Ctr Birth Defects & Developmental Disabil, Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1089/jwh.2005.14.104
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Questions about medication use during pregnancy and lactation are a concern for women and healthcare providers. Unfortunately, there is little experience with the use of most medications in human pregnancy and lactation at the time they are marketed. Even when information is available, it may not be readily accessible to women and healthcare providers. Nevertheless, medication use by pregnant and breastfeeding women may be beneficial, and even essential, to ensure the health of both mother and child. In addition, almost half of pregnancies in the United States each year are unintended, and medication exposures may occur in the early weeks of gestation before a pregnancy is recognized. For these reasons, it is critical that up-to-date information about the effects of medication use during pregnancy and lactation and the management of maternal conditions be available to women and healthcare providers. A comprehensive, coordinated public health approach that builds on and expands existing activities is needed to generate information about medication use, make that information readily available, and translate it into safe and effective healthcare. Critical components of this system include a central source of up-to-date information, further development and coordination of monitoring and research activities, the availability of counseling services throughout the country, development of standard communication messages, and a panel of experts to provide oversight. This will require collaborative support from government agencies, nonprofit organizations, academic and public health professionals, and healthcare providers to ensure safe and beneficial use of medications during pregnancy and lactation.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
  • [21] Medication use during pregnancy and lactation in Mainland China: Based on a national health insurance database in 2015
    Zhang, Jingyuan
    Guan, Xiaodong
    Shi, Luwen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 242 - 242
  • [22] Human Metapneumovirus (HMPV) Outbreak: An Urgent Call for Enhanced Surveillance and Public Health Action
    Kumar, Suresh
    Subramaniam, Gunasekaran
    Kumar, K. J. Senthil
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (02)
  • [23] Mother and Child: Medication Use in Pregnancy and Lactation
    Ito, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (01) : 8 - 11
  • [24] Paracetamol Use During Pregnancy-A Call for Precautionary Action
    Bauer, Ann Z.
    Swan, Shanna H.
    Kriebel, David
    Liew, Zeyan
    Taylor, Hugh S.
    Bornehag, Carl-Gustaf
    Andrade, Anderson M.
    Olsen, Jorn
    Jensen, Rigmor H.
    Mitchell, Rod T.
    Skakkebaek, Niels E.
    Jegou, Bernard
    Kristensen, David M.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (03) : 133 - 134
  • [25] Concerns and implications of Oropouche virus infection during pregnancy: A call for further research and public health action
    Yoosuf, Beema
    Mehta, Rachana
    Sah, Sanjit
    NEW MICROBES AND NEW INFECTIONS, 2025, 63
  • [26] Global heating: an urgent call for action to protect health
    不详
    LANCET, 2022, 400 (10363): : 1557 - 1557
  • [27] Climate change and kidney health: an urgent call to action
    Shah, Ankur D.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (01):
  • [29] ASEAN public health: an urgent call for regional collaboration
    Corpuz, Jeff Clyde G.
    JOURNAL OF PUBLIC HEALTH, 2023, 45 (04) : e804 - e805
  • [30] Methamphetamine Use in Pregnancy: A Call for Action
    Graves, Lisa E.
    Green, Courtney R.
    Robert, Magali
    Cook, Jocelynn L.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (08) : 1001 - 1004